Moody’s Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

TEL AVIV, Israel, May 15, 2025 (Korea Bizwire) – Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody’s Investor Services (“Moody’s”) has raised the company’s corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. Moody’s report cites the Company’s strengths which include significant global scale, ongoing growth in the company’s branded franchises, stabilization [...]